5 billion acquisition of Belgium-based Solvay Pharmaceuticals.

As disclosed previously, the transaction also includes payments as high as EUR 300 million if certain sales milestones are fulfilled between 2011 and 2013. About Abbott Abbott is usually a global, broad-based healthcare company devoted to the discovery, development, marketing and manufacture of pharmaceuticals and medical products, including nutritionals, diagnostics and devices. The business employs 83 approximately, 000 people and markets its products in more than 130 countries. Abbott’s information releases and other details can be found on the company’s Internet site at.. Abbott Completes Acquisition of Solvay Pharmaceuticals Abbott today announced that it has completed its EUR 4.5 billion acquisition of Belgium-based Solvay Pharmaceuticals, providing Abbott with a large and complementary portfolio of pharmaceutical items and expanding Abbott’s presence in important global emerging markets.Related StoriesNew results reveal association between colorectal cancers and melanoma medication treatmentCrucial change in single DNA base predisposes kids to aggressive form of cancerOvarian cancer individuals with a brief history of oral contraceptive make use of have better outcomesBreast cancers remains the next leading reason behind deaths among women in the usa. In 2015, based on the National Cancers Institute, 231,840 females will be diagnosed with the condition and 40,290 will die from it.